BeOne Medicines AG
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| BEIGF | GMAB | BNTX | AAPG | NRIX | TGTX | |
|---|---|---|---|---|---|---|
| Market cap | 32.46B | 22.75B | 22.03B | 1.44B | 2.67B | 8.26B |
| P/E (TTM) | 51.0 | 29.1 | — | — | 10.0 | 19.6 |
| Forward P/E | — | 24.4 | -15.6 | -23.8 | -19.1 | 19.9 |
| Price/book | 6.2 | 3.7 | 1.1 | 17.2 | 2.8 | 12.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +37.59% | +21.15% | −18.75% | −56.47% | +135.03% | +53.67% |
| Today | 0.00% | −2.17% | −2.76% | +5.93% | −2.12% | −3.62% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All BEIGF news ›BeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026
BeOne Medicines (ONC) will present solid tumor pipeline and TEVIMBRA data at the ESMO Congress on October 23–27, 2026, in Madrid. New data from four priority programs, including the GPC3x4-1BB bispecific antibody, CEA targeting ADC, CDK4…
BeOne Medicines (NASDAQ:ONC) Insider Sells $10,890,166.73 in Stock
Posted by Defense World Staff on Oct 18th, 2026 Xiaodong Wang also recently made the following trade(s): Get Our Latest Report on ONC BeOne Medicines Ltd. (NASDAQ: ONC) is a global oncology company focused on discovering, developing,…
TB Alternative Assets Ltd. Makes New $5.42 Million Investment in BeOne Medicines Ltd. - Sponsored ADR $ONC
Check Out Our Latest Stock Report on ONC BeOne Medicines Ltd. NASDAQ: ONC is a global oncology company focused on discovering, developing, manufacturing and commercializing medicines for people with cancer. The company operates across the…
Chronic Lymphocytic Leukemia (CLL) Therapeutics Market to Reach US$ 10.27 Billion by 2035 at 5.5% CAGR; Rising Demand for Targeted Cancer Treatments Drives Growth - Key Players: BeOne Medicines, AstraZeneca, AbbVie
The global chronic lymphocytic leukemia CLL therapeutics market is expanding as treatment strategies increasingly shift toward targeted medicines combination regimens and therapies designed to improve long term disease management Growing…
Sanders Morris Harris LLC Makes New Investment in BeOne Medicines Ltd. - Sponsored ADR $ONC
Sanders Morris Harris LLC bought a new position in shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC - Free Report) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange…
Amanda Pullinger: Cancer Care Leaders Gather at BeOne Medicines to Discuss Artificial Intelligence
Amanda Pullinger, Co – Founder at Global Female Investors Management, LLC, shared on LinkedIn: “Great to be at Be One Medicines at their Hopewell NJ campus today for a leadership summit on Defining AI in cancer care. Wonderful to be with…
BeOne Medicines (NASDAQ:ONC) Stock Falls 5.8% – Here’s What Happened
Posted by Michael Walen on Oct 8th, 2026 BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC – Get Free Report)’s share price fell 5.8% during trading on Thursday. The company traded as low as $341.74 and last traded at $342.7650.…
BeOne Medicines (NASDAQ:ONC) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says
Posted by Sarita Garza on Oct 8th, 2026 Read Our Latest Analysis on ONC BeOne Medicines Ltd. (NASDAQ: ONC) is a global oncology company focused on discovering, developing, manufacturing and commercializing medicines for people with cancer.…
Europe for life sciences and for patients, with BeOne Medicines
Europe continues to offer major life sciences advantages: deep scientific talent, strong clinical expertise, mature research infrastructure, and significant manufacturing capability. Indeed, biotech companies continue to invest in Europe…
BeOne Medicines Successfully Completes Negotiations with the pan-Canadian Pharmaceutical Alliance (pCPA) for TEVIMBRA® in first-line Recurrent or Metastatic Nasopharyngeal Carcinoma
Oct 06, 2026, 06:00 ET Milestone marks an important step forward for Canadians with rare form of head and neck cancer TORONTO, Oct. 6, 2026 /CNW/ -- BeOne Medicines, a global oncology company, today announced the successful completion of…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
marketbeat.com4
-
themarketsdaily.com2
-
defenseworld.net1
-
gurufocus.com1
-
investors.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 10 articles, not a forecast.